Blog / 2014

Conducting a clinical safety review in drug development: the regulatory environment

Posted on 10 December 2014 in Clinical Trials

Regulatory bodies have increased the pressure on pharmaceutical companies to measure and monitor the risk of cognitive adverse events associated with investigational treatments. Scientist and Product Specialist at Cambridge Cognition, Linda Hermans looks at assessing cognitive safety in clinical trials. 

Read on

What is Mild Cognitive Impairment (MCI)?

Posted on 19 November 2014 in Clinical Trials / Healthcare / Research

Amnestic Mild Cognitive Impairment (MCI) is a condition characterised predominantly, but not exclusively, by problems with episodic memory. These memory complaints are measurable with cognitive tests and noticeable by the relatives and friends of the patient. 

Read on

Cantab Connect: the leading cognitive testing technology [video]

Posted on 31 October 2014 in Clinical Trials / Research

Cantab Connect combines leading neuroscience with innovative cloud technology for smarter cognitive testing.

Read on

Cognitive Research Update - Decision making in young people at familial risk of depression

Posted on 22 September 2014 in Clinical Trials / Research

New peer-reviewed papers added to the Cantab Bibliography within the last two weeks.

Read on